Lakeside Partners with Huiyu Pharmaceutical to Revolutionize Oncology Drug Distribution
ITASCA, Ill., Jan. 7, 2025 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market today announced that Hupan Pharmaceutical has entered into a strategic distribution agreement with Sichuan Huiyu Pharmaceutical Co., Ltd. ("Huiyu Pharmaceutical"). Huiyu Pharmaceutical is a leading innovator in oncology and immune-related therapies, listed on the Shanghai Stock Exchange (688553 ...